Walethmade%2525252525252525252525252525252525252525252525252525252525252520bromide

# Walethmade bromide *Note: There is no pharmaceutical agent known as "Walethmade bromide." It is likely you are referring to **Aclidinium bromide**, a long-acting muscarinic antagonist (LAMA).* ## Overview Aclidinium bromide is a long-acting inhaled anticholinergic (muscarinic receptor antagonist) used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). It acts by inhibiting M3 receptors in airway smooth muscle, leading to bronchodilation. ## Primary Indications * Maintenance treatment of patients with COPD, including chronic bronchitis and emphysema. ## Adult Dosing * **Maintenance:** 400 mcg inhaled twice daily via the Genuair/Pressair inhaler (multi-dose dry powder inhaler). * Maximum dose is 400 mcg twice daily. ## Pediatric Dosing * **Safety and efficacy not established.** Not approved for use in pediatric patients. ## Dose Adjustments * **Renal/Hepatic Impairment:** No dosage adjustment is required. ## Contraindications * Hypersensitivity to aclidinium bromide, atropine, or derivatives. * Not indicated for the relief of acute bronchospasm (rescue therapy). ## Adverse Effects * **Common:** Headache, nasopharyngitis, cough, sinusitis. * **Serious:** Paradoxical bronchospasm, worsening of narrow-angle glaucoma, urinary retention (due to anticholinergic effects), and hypersensitivity reactions. ## Key Drug Interactions * **Anticholinergics:** Use with other anticholinergic-containing drugs (e.g., tiotropium, ipratropium) increases the risk of systemic anticholinergic adverse effects. Avoid concurrent use. ## Monitoring * Monitor for paradoxical bronchospasm upon the first dose. * Monitor for signs of increased intraocular pressure (glaucoma) or urinary retention. * Assess COPD symptom control and frequency of rescue medication use. ## Clinical Pearls * **Technique:** Instruct patients on the proper use of the dry powder inhaler; the device provides visual and audible confirmation (green/red window and a "click") when the dose has been correctly inhaled. * **Rescue Use:** Emphasize that aclidinium is for **maintenance only** and should not be used as a rescue medication for acute asthma or COPD exacerbations. * **Systemic Effects:** While absorption is minimal, patients with existing prostatic hyperplasia or bladder neck obstruction should be monitored for urinary difficulty. *** **Educational Disclaimer:** This information is for educational purposes only. Clinical practice varies by region and institution. Always verify specific dosing, safety profiles, and indications through current primary literature, official product labeling (FDA/EMA package inserts), and local hospital protocols before prescribing or administering medication.